NCI-H1703 Xenograft
Rincon Bio performs NCI-H1703 xenograft models to test efficacy of preclinical therapies. Please see below for additional information or to request a quote.
Lung
Organism: Homo sapiens, human / Cell Type: squamous cell / Tissue: lung / Disease: lung; squamous cell; non-small cell lung cancer
Notes
NCI-H1703 was derived from a stage 1 lung squamous cell carcinoma of a 54-year-old Caucasian male smoker.
in vivo
Used in xenografts to test the efficacy of novel cancer therapeutics. Tumors develop after being injected into the flank of immunocompromised mice.
Request Quote
Receive a quote within one business day for a NCI-H1703 Xenogrft
Rincon Bio Growth Curve
Cell Line: NCI-H1703
Mouse Strain: Nude
Positive Control: None
Concentration: N/A
Matrigel: Yes
Dosing: N/A
Stratified: N/A
From implant to stratification: N/A
Cells Implanted per Animal: 4 million
WHY WORK WITH
RINCON BIO?
DOMESTIC QUALITY at COMPETITIVE PRICES
When you work with Rincon Bio, rest assured that all cancer efficacy studies will be performed in the USA, at competitive prices
PERSONAL TOUCH
We love our clients! We are flexible and easy to work with. And we take a personal interest in our clients' studies.